8-91071242-CAT-C
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_016023.5(OTUD6B):c.189_190del(p.His63GlnfsTer12) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000062 in 1,613,704 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Pathogenic (★★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: 𝑓 0.000013 ( 0 hom., cov: 33)
Exomes 𝑓: 0.0000055 ( 0 hom. )
Consequence
OTUD6B
NM_016023.5 frameshift
NM_016023.5 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 8.61
Genes affected
OTUD6B (HGNC:24281): (OTU deubiquitinase 6B) This gene encodes a member of the ovarian tumor domain (OTU)-containing subfamily of deubiquitinating enzymes. Deubiquitinating enzymes are primarily involved in removing ubiquitin from proteins targeted for degradation. This protein may function as a negative regulator of the cell cycle in B cells. [provided by RefSeq, Nov 2013]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 18 ACMG points.
PVS1
?
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
?
Very rare variant in population databases, with high coverage;
PP5
?
Variant 8-91071242-CAT-C is Pathogenic according to our data. Variant chr8-91071242-CAT-C is described in ClinVar as [Pathogenic]. Clinvar id is 967815.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
OTUD6B | NM_016023.5 | c.189_190del | p.His63GlnfsTer12 | frameshift_variant | 2/7 | ENST00000404789.8 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
OTUD6B | ENST00000404789.8 | c.189_190del | p.His63GlnfsTer12 | frameshift_variant | 2/7 | 1 | NM_016023.5 |
Frequencies
GnomAD3 genomes ? AF: 0.0000131 AC: 2AN: 152094Hom.: 0 Cov.: 33
GnomAD3 genomes
?
AF:
AC:
2
AN:
152094
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000119 AC: 3AN: 251048Hom.: 0 AF XY: 0.0000221 AC XY: 3AN XY: 135682
GnomAD3 exomes
AF:
AC:
3
AN:
251048
Hom.:
AF XY:
AC XY:
3
AN XY:
135682
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000547 AC: 8AN: 1461492Hom.: 0 AF XY: 0.00000963 AC XY: 7AN XY: 727050
GnomAD4 exome
AF:
AC:
8
AN:
1461492
Hom.:
AF XY:
AC XY:
7
AN XY:
727050
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome ? AF: 0.0000131 AC: 2AN: 152212Hom.: 0 Cov.: 33 AF XY: 0.00 AC XY: 0AN XY: 74402
GnomAD4 genome
?
AF:
AC:
2
AN:
152212
Hom.:
Cov.:
33
AF XY:
AC XY:
0
AN XY:
74402
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Intellectual developmental disorder with dysmorphic facies, seizures, and distal limb anomalies Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Neuberg Centre For Genomic Medicine, NCGM | - | The frame shift c.189_190del (p.His63GlnfsTer12) variant in OTUD6B gene has been reported Pathogenic in ClinVAR. This variant is reported with the allele frequency 0.001% in the gnomAD and novel in 1000 genome database. This sequence change creates a premature translational stop signal (p.His93Glnfs*12) in the OTUD6B gene. This variant is predicted to cause loss of normal protein function through protein truncation. Loss-of-function variants in OTUD6B are known to be pathogenic (Santiago-Sim T et al.,2017). For these reasons, this variant has been classified as Pathogenic. - |
not provided Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Invitae | Nov 07, 2019 | For these reasons, this variant has been classified as Pathogenic. Loss-of-function variants in OTUD6B are known to be pathogenic (PMID: 28343629). This variant has not been reported in the literature in individuals with OTUD6B-related conditions. This variant is present in population databases (rs779499353, ExAC 0.006%). This sequence change creates a premature translational stop signal (p.His93Glnfs*12) in the OTUD6B gene. It is expected to result in an absent or disrupted protein product. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at